Tamara Dejneka

607 total citations
13 papers, 264 citations indexed

About

Tamara Dejneka is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tamara Dejneka has authored 13 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tamara Dejneka's work include Renin-Angiotensin System Studies (4 papers), Organophosphorus compounds synthesis (3 papers) and Chemical Synthesis and Analysis (2 papers). Tamara Dejneka is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Organophosphorus compounds synthesis (3 papers) and Chemical Synthesis and Analysis (2 papers). Tamara Dejneka collaborates with scholars based in United States, Germany and Malaysia. Tamara Dejneka's co-authors include Edward W. Petrillo, Jack M. DeForrest, Melanie J. Loots, Michael C. Badia, David W. Cushman, Donald S. Karanewsky, J.R. Powell, E. R. WEAVER, William H. Koster and Denis E. Ryono and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Tamara Dejneka

13 papers receiving 244 citations

Peers

Tamara Dejneka
R. Tonani Italy
Neil V. Harris United Kingdom
Paul L. Creger United States
Kuo-Chi Cheng United States
Ellen Sieber-McMaster United States
Ervin R. Spitzmiller United States
Peter H. Crackett United Kingdom
Dulce Garrido United States
Narendra Panday Switzerland
Harriet W. Hamilton United States
R. Tonani Italy
Tamara Dejneka
Citations per year, relative to Tamara Dejneka Tamara Dejneka (= 1×) peers R. Tonani

Countries citing papers authored by Tamara Dejneka

Since Specialization
Citations

This map shows the geographic impact of Tamara Dejneka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Dejneka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Dejneka more than expected).

Fields of papers citing papers by Tamara Dejneka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Dejneka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Dejneka. The network helps show where Tamara Dejneka may publish in the future.

Co-authorship network of co-authors of Tamara Dejneka

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Dejneka. A scholar is included among the top collaborators of Tamara Dejneka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Dejneka. Tamara Dejneka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hangeland, Jon J., Arthur M. Doweyko, Tamara Dejneka, et al.. (2004). Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta. Bioorganic & Medicinal Chemistry Letters. 14(13). 3549–3553. 47 indexed citations
2.
Sun, Chong‐Qing, Peter T. W. Cheng, Tamara Dejneka, et al.. (2002). A general synthesis of dioxolenone prodrug moieties. Tetrahedron Letters. 43(7). 1161–1164. 13 indexed citations
3.
Lloyd, John, Denis E. Ryono, J. Eileen Bird, et al.. (1994). Quinoline-4-carboxylic acids as angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 195–200. 10 indexed citations
4.
Ryono, Denis E., John Lloyd, Michael A. Poss, et al.. (1994). Orally active prodrugs of quinoline-4-carboxylic acid angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 201–206. 22 indexed citations
5.
Poss, Michael A., Zhengxiang Gu, Denis E. Ryono, et al.. (1994). 1,4-substituted indoles: a potent and selective class of angiostensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 145–150. 10 indexed citations
6.
Poss, Michael A., Charles A. Free, W. Lynn Rogers, et al.. (1993). Diol sulfonamides: A potent and novel class of inhibitors of human renin. Bioorganic & Medicinal Chemistry Letters. 3(12). 2739–2744. 4 indexed citations
7.
Karanewsky, Donald S., Michael C. Badia, David W. Cushman, et al.. (1990). (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogs of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline. Journal of Medicinal Chemistry. 33(5). 1459–1469. 18 indexed citations
8.
Norman, Jon, et al.. (1989). Affinity purification of endothia protease with a novel renin inhibitor, SQ 32,970. Biochemical and Biophysical Research Communications. 161(1). 1–7. 5 indexed citations
9.
Karanewsky, Donald S., Michael C. Badia, David W. Cushman, et al.. (1988). (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline, a novel orally active inhibitor of ACE. Journal of Medicinal Chemistry. 31(1). 204–212. 82 indexed citations
10.
SLUSARCHYK, W. A., Tamara Dejneka, Jack Z. Gougoutas, et al.. (1986). β-Lactam synthesis: Chemospecific sulfonation and cyclization of the β-hydroxyvaline nucleus. Tetrahedron Letters. 27(25). 2789–2792. 18 indexed citations
11.
Slusarchyk, William A., Tamara Dejneka, Eric M. Gordon, E. R. WEAVER, & William H. Koster. (1984). Monobactams: Ring Activating N-1-Substituents in Monocyclic b-Lactam Antibiotics. Heterocycles. 21(1). 191–191. 28 indexed citations
12.
SLUSARCHYK, W. A., Tamara Dejneka, Eric M. Gordon, E. R. WEAVER, & William H. Koster. (1984). ChemInform Abstract: MONOBACTAMS: RING ACTIVATING N‐1‐SUBSTITUENTS IN MONOCYCLIC β‐LACTAM ANTIBIOTICS. Chemischer Informationsdienst. 15(40). 4 indexed citations
13.
Simon, Ernst, et al.. (1977). 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino [3,2-b]quinazolin-10(2H)-ones.. Arzneimittelforschung. 27(4). 766–70. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Tonani Breakdown of academic impact, for papers by Neil V. Harris Breakdown of academic impact, for papers by Paul L. Creger Breakdown of academic impact, for papers by Kuo-Chi Cheng Breakdown of academic impact, for papers by Ellen Sieber-McMaster Breakdown of academic impact, for papers by Ervin R. Spitzmiller Breakdown of academic impact, for papers by Peter H. Crackett Breakdown of academic impact, for papers by Dulce Garrido Breakdown of academic impact, for papers by Narendra Panday Breakdown of academic impact, for papers by Harriet W. Hamilton
Rankless by CCL
2026